UPC — Universe Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual balance sheet for Universe Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	R2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	10.1	21.8	18.9	6.65	30.9
Net Total Accounts Receivable
Net Total Receivables	10.9	15.6	15.2	11.6	17
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23.3	50.5	41.5	25.3	51.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.43	15.4	13.6	12.8	13.1
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	28.8	70.1	59.5	41.7	68
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8	11.2	13.1	13.8	20.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	8	11.2	13.1	13.8	22.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	20.8	58.9	46.4	28	45.5
Total Liabilities & Shareholders' Equity	28.8	70.1	59.5	41.7	68
Total Common Shares Outstanding